Table 2.
Power for effects of a single agent on recurrent depression in VITAL-DEP, over 5 years of follow-up.
RR† | Total | Women | Men | Non-Hispanic White | Minority | African-American |
---|---|---|---|---|---|---|
2,730 ‡ | 1,856 ‡ | 874 ‡ | 1,777 ‡ | 953 ‡ | 683 ‡ | |
0.90 | 38.2% | 30.8% | 12.7% | 26.7% | 16.4% | 12.9% |
0.85 | 70.9% | 59.6% | 23.5% | 52.6% | 31.6% | 24.0% |
0.80 | 92.1% | 84.1% | 38.5% | 77.7% | 51.3% | 39.2% |
0.75 | 98.9% | 96.1% | 55.7% | 92.9% | 70.9% | 56.5% |
0.70 | >99.9% | 99.5% | 72.2% | 98.6% | 85.9% | 72.9% |
0.65 | >99.9% | >99.9% | 85.2% | 99.8% | 94.7% | 85.6% |
0.60 | >99.9% | >99.9% | 93.4% | >99.9% | 98.5% | 93.6% |
Expected RR;
Expected total number of eligible participants.